Hiroaki Akamatsu
- Pulmonary and Respiratory Medicine top 0.5%
- Oncology top 0.5%
- Molecular Biology top 10%
- Cancer Research top 1%
- Epidemiology top 10%
- Co-authors
- Yi‐Long WuSuresh S. RamalingamMyung‐Ju AhnHelen MannYong HeTony MokWillemijn S.M.E. TheelenMartin Sebastian
- Topics
- Lung Cancer Treatments and Mutations (82 papers)Lung Cancer Research Studies (52 papers)Lung Cancer Diagnosis and Treatment (28 papers)
- Journals
- New England Journal of MedicineJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesSouth Korea
In The Last Decade
Hiroaki Akamatsu
135 papers receiving 5.0k citations
Hit Papers
Peers
Comparison fields: 5 of 107
- Pulmonary and Respiratory Medicine 3.8k
- Oncology 3.5k
- Molecular Biology 1.2k
- Cancer Research 1.1k
- Epidemiology 309
Countries citing papers authored by Hiroaki Akamatsu
This map shows the geographic impact of Hiroaki Akamatsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroaki Akamatsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroaki Akamatsu more than expected).
Fields of papers citing papers by Hiroaki Akamatsu
This network shows the impact of papers produced by Hiroaki Akamatsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroaki Akamatsu. The network helps show where Hiroaki Akamatsu may publish in the future.
Co-authorship network of co-authors of Hiroaki Akamatsu
This figure shows the co-authorship network connecting the top 25 collaborators of Hiroaki Akamatsu. A scholar is included among the top collaborators of Hiroaki Akamatsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroaki Akamatsu. Hiroaki Akamatsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 1 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 12 | |
| 7 | 2 | |
| 8 | 4 | |
| 9 | 4 | |
| 10 | 2 | |
| 11 | 4 | |
| 12 | 3 | |
| 13 | 22 | |
| 14 | 53 | |
| 15 | 44 | |
| 16 | 109 | |
| 17 | 2 | |
| 18 | 12 | |
| 19 | 18 | |
| 20 | 10 |
About Hiroaki Akamatsu
Hiroaki Akamatsu is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 144 papers that have together received 5.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (82 papers), Lung Cancer Research Studies (52 papers) and Lung Cancer Diagnosis and Treatment (28 papers). The work is most often cited by research in Oncology (3.5k citations), Pulmonary and Respiratory Medicine (3.8k citations) and Cancer Research (1.1k citations). Hiroaki Akamatsu has collaborated with scholars based in Japan, United States and South Korea. Frequent co-authors include Yi‐Long Wu, Suresh S. Ramalingam, Myung‐Ju Ahn, Helen Mann, Yong He, Tony Mok, Willemijn S.M.E. Theelen, Martin Sebastian, Frances A. Shepherd and Vassiliki A. Papadimitrakopoulou. Their work appears in journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.